Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

Ferrara, Felicetto

Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia? [electronic resource] - Hematological oncology Mar 2014 - 1-9 p. digital

Publication Type: Comparative Study; Journal Article; Review

1099-1069

10.1002/hon.2046 doi


Age Factors
Aged
Antimetabolites, Antineoplastic--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Azacitidine--administration & dosage
Combined Modality Therapy
Comorbidity
Consolidation Chemotherapy
DNA Methylation--drug effects
DNA, Neoplasm--metabolism
DNA-Cytosine Methylases--antagonists & inhibitors
Decitabine
Enzyme Inhibitors--administration & dosage
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute--drug therapy
Middle Aged
Molecular Targeted Therapy
Multicenter Studies as Topic
Neoplasm Proteins--antagonists & inhibitors
Prognosis
Randomized Controlled Trials as Topic
Remission Induction
Survival Rate
Treatment Outcome